Parminder S Chaggar

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 372 citations · Full text

Medicine, Cardiology, Internal Medicine +11

Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial

John G.F. Cleland, Philip A. Kalra, Pierpaolo Pellicori et al. · European Heart Journal · 2024 · 39 citations · Full text

Medicine, Hematology, Internal Medicine +17

The Efficacy and Tolerability of Ezetimibe in Cardiac Transplant Recipients Taking Cyclosporin

Steven M. Shaw, Parminder S Chaggar, James Ritchie et al. · Transplantation · 2009 · 31 citations

Medicine, Pharmacology, Pharmacotherapy +14

Primary care heart failure service identifies a missed cohort of heart failure patients with reduced ejection fraction

Matthew Kahn, Antony D. Grayson, Parminder S Chaggar et al. · European Heart Journal · 2021 · 29 citations · Full text

Medicine, Cardiology, Family Medicine +14

Prolonged Asystole in a Patient With an Isolated Left Ventricular Assist Device

Wasim Javed, Parminder S Chaggar, Rajamiyer Venkateswaran et al. · Future Cardiology · 2016 · 10 citations

Medicine, Cardiology, Surgery +15